Latest 10-Q quarterly reports

BEST SPAC I Acquisition Corp. reports significant share redemptions and extends its business combination deadline to June 16, 2027, while facing substantial doubt about its going concern.

Five9, Inc. announced its second quarter 2026 financial results, showcasing a 10% increase in revenue and a significant rise in net income compared to the prior year period.

Structure Therapeutics Inc. filed its Form 10-Q for the period ended June 30, 2026, detailing increased R&D expenses and a substantial net loss, while highlighting progress in its clinical pipeline.

Senseonics Holdings, Inc. Q2 2026 filing shows a substantial increase in total revenue and gross profit, driven by US sales growth and the 365-day product, alongside significant investments in R&D and SG&A.

Bridger Aerospace Group Holdings, Inc. reported a net loss of $0.5 million for the second quarter of 2026, with revenues slightly decreasing by 1% year-over-year, impacted by a significant drop in MRO and Other Services revenue.

Talkspace reported a 13.6% revenue increase in Q2 2026 driven by Payor segment growth, but also saw a significant rise in G&A expenses due to merger-related costs.

PDF Solutions, Inc. announced robust financial results for the second quarter of 2026, showcasing significant revenue increases and a return to net income, bolstered by a successful secondary offering.

OmniAb, Inc. announced its second quarter 2026 financial results, showcasing a substantial increase in total revenue driven by license and milestone payments, while continuing to report net losses and a decrease in cash reserves.

Howmet Aerospace Inc. reported a substantial increase in second-quarter 2026 revenue and net income, driven by strong performance in aerospace markets and strategic acquisitions.

RXO, Inc. reported a 25% revenue increase for Q2 2026, reaching $1.8 billion, but continued to post net losses and saw its cost of transportation services rise as a percentage of revenue.

Red Cat Holdings, Inc. (RCAT) announced a substantial increase in revenues for the quarter ended June 30, 2026, driven by expanded drone deliveries and strategic acquisitions, alongside increased operating expenses.

Aeva Technologies (AEVA) filed its Q2 2026 10-Q, revealing a significant increase in professional services revenue but continued operating losses and a substantial cash burn, raising concerns about future liquidity.

Lyell Immunopharma's Q2 2026 report shows continued net losses and operating expenses, though progress is noted in its CAR T-cell therapy development for LBCL and mCRC.

Alpha Teknova's Q2 2026 Form 10-Q reveals an 18.5% revenue increase to $12.2 million, but operating losses widened due to higher sales and marketing expenses.

MBIA Inc. filed its Q2 2026 10-Q, detailing continued net losses and ongoing legal battles, particularly concerning the PREPA restructuring, while also noting a slight improvement in statutory capital for its subsidiaries.

MetaVia Inc. reported increased R&D expenses and a widening net loss for Q2 2026, while acknowledging substantial doubt about its ability to continue as a going concern.

Arlo Technologies Inc. announced a significant increase in total revenue and gross profit for the second quarter of 2026, driven by subscription growth and strategic acquisitions.

NextCure, Inc. reported its Q2 2026 results, detailing a significant net loss and substantial doubt about its going concern status, while simultaneously announcing a proposed merger with Avere Therapeutics and a comprehensive restructuring plan.

Cloudflare, Inc. filed its Form 10-Q for the period ended June 30, 2026, reporting increased revenue but also significant net losses and substantial restructuring charges related to an AI-first operating model evolution.

vTv Therapeutics Inc. filed its Form 10-Q for the quarter ended June 30, 2026, reporting $36.8 million in revenue driven by licensing agreements, but also significant operating losses and a substantial accumulated deficit.

Plexus Corp. announced a significant increase in net sales for the third quarter of fiscal year 2026, driven by robust performance across key market sectors and geographic regions.

Post Holdings reported a 2% decrease in net sales for the third quarter, with operating profit down 19%, though year-to-date performance shows growth.

RE/MAX Holdings, Inc. reported a 5.8% decrease in total revenue to $68.5 million and a net loss attributable to the company of $4.3 million for the second quarter of 2026.

Vaxart, Inc. reported a net loss of $13.5 million for Q2 2026, with a significant reduction in government contract revenue and continued operational expenses, alongside its delisting from Nasdaq.

Surrozen, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing progress in its Wnt pathway modulation platform for ophthalmology and reporting a net loss.

First Northwest Bancorp reported stable net interest income and a slight increase in total assets for Q2 2026, while managing deposit costs and navigating legal challenges.

Pulse Biosciences, Inc. reported its Q2 2026 results, highlighting progress in cardiac device development while continuing to incur significant operating losses and relying on equity financing.

Amprius Technologies Inc. announced a significant increase in revenue for the second quarter of 2026, driven by strong sales of its SiCore batteries, though the company continues to operate at a net loss.

Lionsgate Studios Corp. reported a substantial increase in Q1 FY27 revenue, primarily fueled by strong performance in its Motion Picture segment, while Television Production saw a decline.

World Acceptance Corporation announced a substantial increase in net income and operating income for the first quarter ended June 30, 2026, driven by higher revenues and reduced credit loss provisions.